Kimya & İlaç — Avustralya Borsası Sektör Analizi

Total Market Cap 25.8B

P/E (Weighted)Price to Earnings ratio. 8.38 Medyan: 6.12

P/B (Weighted)Price to Book ratio. 5.00 Medyan: 1.97

P/E (Arithmetic)Simple average P/E. 6.99

Avg Lothien ScoreFinancial health score (0-100). 65

Avg DamodaranDamodaran scoring model. 51

Avg PotentialExpected upside potential %. +54.5%

Avg Dalio ScoreDalio debt cycle score. 61

Distributions

Lothien Distribution

0–25

25–40

40–55

55–70

70–100

Damodaran Distribution

0–25

25–40

40–55

55–70

70–100

Upside Potential

-100% – -20%

-20% – +0%

+0% – +20%

+20% – +50%

+50%+

Stocks in Sector

Stock	PriceCurrent trading price.	Market CapTotal market capitalization.	FKPrice to Earnings ratio.	PD/DDPrice to Book ratio.	EV/EBITDAEnterprise Value / EBITDA.	ROICReturn on Invested Capital.	WACCWeighted Average Cost of Capital (WACC).	PUSLAFinancial health score (0-100).	DamodaranValuation score.	Intrinsic ValueFair value via DCF model.	Potential %Expected upside potential %.	Dalio RiskDalio Debt Cycle Score	Debt/EquityDebt to Equity ratio.
ELD	6.02	1.3B	5.76	1.04	3.21	4.7%	9.1%	78	58	12.34	+78.7%	61	0.79
DNL	3.78	6.6B	6.48	1.64	2.36	7.1%	10.3%	77	61	6.98	+63.5%	67	0.40
ORA	1.46	1.8B	—	0.92	1.56	6.4%	9.4%	76	63	3.44	+100.0%	71	0.60
ING	2.03	754.5M	5.45	2.95	2.42	6.2%	7.5%	71	63	3.53	+55.7%	50	6.09
NUF	3.17	1.2B	—	257.8M	1.97	12.7%	8.9%	70	67	7.25	+72.2%	56	218.0M
RIC	2.62	982.1M	8.91	1.97	2.77	6.9%	8.9%	69	59	4.18	+44.7%	60	1.66
ORI	22.23	10.3B	10.28	1.3B	2.32	26.1%	10.0%	68	76	29.03	+22.0%	56	402.5M
SHV	4.50	639.5M	5.37	1.17	1.96	-1.7%	10.5%	68	36	8.90	+62.7%	59	0.70
INR	0.11	339.6M	—	0.88	—	-2.8%	14.3%	58	32	0.33	+100.0%	67	0.00
GLN	0.41	513.4M	—	2.07	—	-2.9%	14.3%	45	23	0.52	+13.6%	67	0.00
CBO	2.90	1.4B	—	2.72	7.43	-1.0%	10.7%	36	25	2.11	-13.8%	57	0.88